先天性风疹综合征监测进展和方法综述  

Progress toward congenital rubella syndrome surveillance and surveillance methods:a literature review

作　　者：许侠 刘斯宇 唐林 刘倩倩 尹遵栋[1,2] 王富珍[1,2] Xu Xia;Liu Siyu;Tang Lin;Liu Qianqian;Yin Zundong;Wang Fuzhen(National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases,Chinese Center for Disease Control and Prevention,Beijing 102206,China;National Immunization Program,Chinese Center for Disease Control and Prevention,Beijing 100050,China)

机构地区：[1]传染病溯源预警与智能决策全国重点实验室,中国疾病预防控制中心,北京102206 [2]中国疾病预防控制中心免疫规划中心,北京100050

出　　处：《中国疫苗和免疫》2023年第6期719-726,共8页Chinese Journal of Vaccines and Immunization

基　　金：中国CDC公共卫生应急反应机制的运行(131031001000150001)。

摘　　要：先天性风疹综合征(Congenital rubella syndrome,CRS)是妊娠早期风疹病毒感染所导致的严重出生缺陷,世界卫生组织估计每年发生约10万例CRS病例,造成沉重的家庭经济负担和社会负担。保持含风疹成分疫苗高覆盖率和开展高质量病例监测是控制和消除风疹和CRS的重要措施。本文综述了近年来国内外CRS监测进展和方法,为制订中国CRS监测策略提供参考。Congenital rubella syndrome(CRS) is a constellation of serious birth defects caused by primary rubella virus infection in the first trimester of pregnancy.The World Health Organization estimates that approximately 100 000 CRS cases occur per year,leading to heavy economic family and social burdens.High rubella-containing vaccine(RCV) coverage and high-quality case surveillance are important to control and eliminate rubella and CRS.In this article,we summarize the status and method of CRS surveillance at home and abroad to provide reference for developing CRS surveillance strategies in China.

关 键 词：先天性风疹综合征 监测 含风疹成分疫苗 

分 类 号：R186[医药卫生—流行病学]